Low Hemoglobin Predicts Radiographic Damage Progression in Early Rheumatoid Arthritis – Secondary Analysis from a Phase III trial
ConclusionLow hemoglobin is a DAS28‐CRP‐independent predictor of radiographic joint damage progression in MTX‐treated patients with early RA. This effect decreases over time in ADA‐ and in combination‐treated patients, and in clinical responders irrespective of treatment modality.This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Burkhard M öller, Judith Everts‐Graber, Stefan Florentinus, Yihan Li, Hartmut Kupper, Axel Finckh Tags: Original Article Source Type: research
More News: Anemia | Arthritis | Humira | International Medicine & Public Health | Methotrexate | Radiography | Rheumatoid Arthritis | Rheumatology | Study | WHO | Women